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The baculovirus Autographa californica nucleopolyhedrovirus encodes two proteins with RNA triphosphatase
activity. Late expression factor LEF-4, which is an essential gene, is a component of the RNA polymerase and
also encodes the RNA capping enzyme guanylyltransferase. PTP/BVP is also an RNA triphosphatase, but is not
essential for viral replication, possibly because its activity is redundant to that of LEF-4. To elucidate the role
of these proteins in mRNA cap formation, a mutant virus that lacked both RNA triphosphatase activities was
constructed. Infection studies revealed that the double-mutant virus was viable and normal with respect to the
production of budded virus. Pulse-labeling studies and immunoblot analyses showed that late gene expression
in the double mutant was equivalent to that in the wild type, while polyhedrin expression was slightly reduced.
Direct analysis of the mRNA cap structure indicated no alteration of cap processing in the double mutant.
Together, these results reveal that baculoviruses replicate and express their late genes at normal levels in the
absence of its two different types of RNA triphosphatases.
Baculoviruses are unique among eukaryotic DNA viruses in
their use of both cellular and viral transcription machinery (19,
25). Viral infection is initiated by the host RNA polymerase II
that recognizes and transcribes early promoters which are
structurally similar to cellular promoters. Late and very late
genes are transcribed by a virus-encoded RNA polymerase
composed of four late expression factors (LEFs) called LEF-4,
-8, and -9 and P47. These genes were first described for the
type species Autographa californica multicapsid nucleopoly-
hedrovirus (AcMNPV), and homologs have been identified in
all the baculovirus genomes that have been sequenced thus far
(45). LEF-8 and LEF-9 are believed to form the catalytic
pocket, because they contain motifs common to  and  RNA
polymerases (38, 49, 59). LEF-4 is an RNA capping enzyme
with both guanylyltransferase and RNA triphosphatase activi-
ties (14, 17, 28), and the function of P47 is unknown.
Late and very late baculovirus mRNAs have a typical methyl-
7-guanosine cap structure at their 5 ends (53). In eukaryotic
cells, this cap structure is essential and is required for efficient
pre-mRNA splicing, export, stability, and translation initiation
(11). Three enzymatic activities are required for cap formation:
hydrolysis of the 5 triphosphate end of the nascent transcript
to a diphosphate by RNA triphosphatase, capping of the
diphosphate end with GMP by RNA cap guanylyltransferase,
and N-7 methylation of guanine cap by RNA cap methyltrans-
ferase (11, 57).
Baculoviruses have evolved a novel strategy for capping their
late mRNAs. Even though they replicate in the nuclei of in-
fected cells, baculoviruses are unable to use the cellular cap-
ping machinery, because these enzymes find their substrates
through interactions with the highly repetitive carboxyl-termi-
nal domain of the cellular RNA polymerase II (6, 23, 43). Since
the baculovirus RNA polymerase lacks this motif, cellular cap-
ping enzymes would not be able to recognize the viral mRNAs.
Therefore, baculoviruses must encode their own capping en-
zymes. This is not uncommon in the virus world, but the in-
corporation of this activity into a DNA-dependent RNA poly-
merase is unique to baculoviruses.
The two enzymatic activities of LEF-4 constitute separable
and autonomous domains (14, 28, 40, 41). The RNA triphos-
phatase activity is N-terminal with guanylyltransferase activity
at the C terminus. The RNA triphosphatase domain belongs to
a family of metal-dependent phosphohydrolases, which also
includes RNA capping enzymes of fungi and protozoa (22).
These enzymes are defined by two essential glutamate-contain-
ing motifs that bind divalent cation. The substitution of any
one of these glutamates abolishes enzymatic activity.
As expected for an RNA polymerase subunit, LEF-4 is es-
sential for viral replication, as revealed by studies of a temper-
ature-sensitive virus with a mutation in lef-4 and by RNA
silencing experiments (30, 47). LEF-4 is also necessary for
transient expression of late and very late genes (48). Recently,
we dissected the requirement of LEF-4 for productive infec-
tion and showed that the essential function of LEF-4 extends
beyond its structural role in transcription (30). In a previous
study, a mutant bacmid containing a disruption in the lef-4
gene was unable to produce progeny virus, but the cotransfec-
tion of a plasmid encoding wild-type (wt) LEF-4 restored virus
production, while cotransfection of a mutant version of LEF-4
with a K255A substitution that abolishes guanylyltransferase
activity did not rescue the phenotype (30). This result demon-
strated that the capping function of LEF-4 is necessary for viral
replication. The question of whether the triphosphatase activ-
ity of LEF-4 is also essential was not addressed in that study.
The issue of LEF-4 RNA triphosphatase activity is compli-
cated by the fact that group I baculoviruses, which include
AcMNPV, encode another protein with the same enzymatic
activity as that of the triphosphatase. This gene was originally
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named ptp (protein tyrosine phosphatase), due to the presence
of a diagnostic P-loop motif that binds the cleavable phosphate
(55). Subsequent research, however, showed that its preferred
substrate was RNA and that it released phosphates from the 5
end of RNA (13, 58). It was renamed bvp (baculovirus phos-
phatase) to reflect its correct function. This name has been
adopted outside the baculovirus field, although ptp is more
commonly used by baculovirologists. Here we refer to it by the
hybrid name ptp/bvp. Crystallographic studies of PTP/BVP
showed that its structure was similar to metazoan RNA cap-
ping enzymes, thus confirming its specificity for RNA sub-
strates (5). Furthermore, in vivo analyses showed that PTP/
BVP could substitute for yeast RNA triphosphatase in the cap
synthetic pathway in yeast cells (42). The biological function of
PTP/BVP within the context of a baculovirus infection is less
well understood. Analyses of mutant viruses showed that ptp/
bvp was not required for viral replication in cell culture or in
larvae (35). Interestingly, insects infected with ptp/bvp mutant
viruses showed altered behavior, suggesting that it was impor-
tant in virus transmission (29).
The existence of two baculovirus RNA triphophatases raises
questions about their roles in regard to viral mRNA capping.
To determine whether the RNA triphosphatase activity of
LEF-4 is absolutely essential or whether PTP/BVP performs a
backup role, we constructed a mutant virus that lacked both
RNA triphosphatase activities by homologous recombination
using a bacmid construct in Escherichia coli. Surprisingly, our
data show that the double-mutant virus was viable and normal
with respect to the production of budded virus and the synthe-
sis of late genes. Furthermore, an analysis of late mRNA cap
structure showed no alteration in cap processing in the double-
mutant virus.
MATERIALS AND METHODS
Viruses and cells. Bacmid bMON14272 (Invitrogen Life Technologies) was
maintained in DH10B cells as described previously (39). It contains a mini-
attTn7 attachment site that allows the generation of recombinant bacmids by the
transposition of donor plasmid pFastBac with helper plasmid pMON7124, which
encodes the transposase (39). The Sf-9 insect cell line, a clonal isolate of IPLB-
Sf21-AE cells derived from the fall armyworm (Spodoptera frugiperda) (60), was
cultured in TNMFH medium supplemented with 10% fetal bovine serum, gen-
tamicin (25 g/ml), and amphotericin (1.25 g/ml). In all experiments, virus
inocula were allowed to adsorb for 1 h at 27°C and then were replaced with fresh
medium. Viral DNA was transfected for 4 h before the medium was changed.
Time zero was defined as the time when the virus was replaced with fresh
medium.
Generation of lef-4 and ptp/bvp double-knockout AcMNPV bacmid. A double-
knockout mutant of AcMNPV was generated in the bacmid bMON14272 by
homologous recombination in E. coli using a modification of the phage red
recombinase system as described previously (3, 8, 37). A lef-4 single knockout was
constructed first. A linear DNA fragment containing the chloramphenicol resis-
tance gene flanked by 50-bp sequences homologous to the 5 and 3 ends of lef-4
was generated from pBR325 by PCR using the primer pair lef4Cm-F and
lef4Cm-R (Table 1). This fragment was coelectroporated with bacmid
bMON14272 DNA into E. coli BW25113-pKD46-competent cells. Potential
clones were selected on LB plates containing chloramphenicol, and isolated
colonies were screened by PCR with the primer pair A/B, followed by restriction
enzyme digestion to confirm the replacement of the lef-4 gene with the chlor-
amphenicol resistance gene. A similar strategy was used to create the double-
knockout construct from the lef-4 single-knockout bacmid. To knock out ptp/bvp,
primers ptpZeo-F and ptpZeo-R were used to generate a linear Zeocin resis-
tance gene fragment with 50-bp sequences homologous to the 5 and 3 regions
of ptp/bvp. This fragment was coelectroporated with the lef-4 single-knockout
bacmid DNA into E. coli BW25113-pKD46-competent cells. Potential recombi-
nants were selected on LB plates containing Zeocin, and isolated colonies were
TABLE 1. Primers used in this studya
Primer name Position no. Sequence Function
lef4Cm-F 76727–76775 GTACGACGAAAACGGCTTTCGCACTCGTATACCTATTCAG
AGCGCTTGCTGTGTAGGCTGGAGCTGCTTCG
lef-4 KO
lef4Cm-R 77981–77933 CACGATTCGGTCGCGACGATGTTTCAACACGTTTATTGTC
GTGTCCGTGCATATGAATATCCTCCTTA
lef-4 KO
ptpZEO-F 509–558 CCCGCGCGTTGGCAAACTATTTACAATGCGGCCAAGTTAT
AAAAGATTCTGTTGACAATTAATCATCGGC
ptp/bvp KO
ptpZEO-R 1080–1031 GGTTCGCTGGAAGAAGCGCAACAATTTGAAAATAGGATA
AAGTATTTGTTCCCGGGAATTCTCAGTCCTGC
ptp/bvp KO
A 373–394 GTGTGCAAAACATGACATCAGC Confirm ptp/bvp KO
B 1265–1285 ACATCCGGTGTTGTGCGTGAC Confirm ptp/bvp KO
C 76504–76525 GACACGATGGACGCGAAAATGC Confirm lef-4 KO
D 78286–78306 CGCCGCCTTCTCCTATTCCTC Confirm lef-4 KO
ptpR-F 287–303 gctactagtGCAAAACATGACATCAG bvp/ptp repair
ptpR-R 988–1006 TTATTAAATTAATAAATCTTGAAC bvp/ptp repair
p6.9polyA-F 86478–86494 gctactagtGGAAAAACATACCAGCA Add polyA signal to
bvp/ptp
p6.9polyA-R 86695–86711 atccccgggCAACCAGACATTCCACAC Add polyA signal to
bvp/ptp
lef4R-F 76238–76254 atcgtcgacCGGCTTGCATCATACTG lef-4 repair
lef4R-R 77970–77987 atccccgggATTTGGCACGATTCGGTC lef-4 repair
vp39polyA- F 75276–75295 CGCTGCATTTAATCACATCC Add polyA signal to
lef-4
vp39polyA-R 75513–75534 gctactagtAAATGGAGTTTGTTAAATTG Add polyA signal to
lef-4
D1/D12 E192/194A-F GGCCTAATACATCTCTGGcAATAGcATTCACACCTAGAGAC Construct RTPase
D1/D12
a Nucleotides added for cloning purposes are shown in lowercase type, restriction enzyme sites are underlined, mutagenic residues are indicated by lowercase bold
type. Primers for lef-4 mutagenesis have been described previously (28). KO, knockout.
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screened by restriction fragment length polymorphism (RFLP)-PCR with the
primer pair C/D to confirm the replacement of ptp/bvp with the Zeocin resistance
gene.
Bacmid bMON14272 is polyhedrin negative, because most of polyhedrin open
reading frame (ORF) was deleted during construction (39). To facilitate the
observation of viral infection, polyhedrin (polh) and green fluorescent protein
(gfp) genes were inserted into the bacmid genomes. The transfer plasmid pFacT-
GFP (a gift from David Theilmann) encoding POLH and GFP was transposed
into the polh locus of bMON14272 to generate the bacmid construct vAc-PG, as
described previously (7).
The pFacT-GFP plasmid was also used to generate different repair versions
containing mutant or wt lef-4 and ptp constructs. The transfer plasmid pFacT-
GFP-lef4 was constructed by cloning a 1,777-bp fragment, containing the wt lef-4
ORF with its native promoter, and a 233-bp fragment, containing the p6.9
poly(A) tail region; the fragments were separately amplified by PCR from the
AcMNPV genome using primer pairs Lef-4R-F and Lef-4R-R or p6.9polyA-F
and p6.9polyA-R, respectively. The lef-4 fragment was digested with SalI and
SmaI and then subcloned into pBS (previously digested with SalI and Smal) to
yield pBS-lef-4R. The p6.9 poly(A) fragment was digested with SpeI and Smal
and then ligated with SpeI- and NotI-digested pBS-lef-4R to construct pBS-lef-
4RA. Then, a SalI/SacII-digested fragment from pBS-lef-4RA was cloned into
SalI/SmaI-digested pRS416 to give pRS416-lef-4RA. Finally, a XhoI/XbaI-di-
gested fragment from pRS416-lef-4RA was subcloned into pFacT-GFP (previ-
ously digested with XhoI and XbaI) to generate pFacT-GFP-lef4.
To construct ptp and lef-4 double-repair viruses, a 744-bp fragment containing
the ptp ORF under its native promoter and a 259-bp fragment containing the
vp39 poly(A) sequence were amplified from the AcMNPV genome. The two
fragments were digested with SpeI and then cloned into pBS (previously digested
with SpeI) to give pBS-ptp. The resulting ptp-polyA cassette was then digested
with SpeI and subcloned into the XbaI site of pFacT-GFP-lef4, thus generating
the double-repair transfer plasmid pFacT-GFP-lef4ptp.
Transfer plasmids encoding mutant versions of lef-4, pFacT-GFP-lef4E2A, and
pFacT-GFPE2Aptp were constructed by QuikChange mutagenesis using the
primers lef-4/E181,183A (28) and following the recommendations of the manu-
facturer (Stratagene). The quadruple mutant was made using the double-mutant
transfer vector as the template and the primers lef-4/E9,11A (28).
Recombinant bacmids were generated by transposition following the Bac-to-
Bac protocol (Invitrogen Life Technologies). The universal M13 reverse primer
and an appropriate gene-specific primer were used for PCR screening of poten-
tial colonies.
Time course analysis of BV production. To assess the effect of ptp/bvp or lef-4
deletions on viral infection, a single-step growth curve was performed. Virus
stock was prepared by transfecting Sf-9 cells (2.0 106 per 35-mm-diameter dish)
with 2.0 g of the appropriate bacmid DNA using Cellfectin (Invitrogen Life
Technologies). The supernatant was harvested after 3 days, and titers were
determined. Cells were infected in duplicate at a multiplicity of infection (MOI)
of 5. One hour after infection, cells were washed twice with fresh medium and
replenished with 2 ml of fresh medium supplemented with 10% fetal bovine
serum. Virus supernatants were collected at selected time points. The titers of
budded virus (BV) were determined by a 50% tissue culture infective dose
(TCID50) end point dilution assay on Sf-9 cells (46).
Radiolabeling of proteins and Western blot analyses. Pulse labeling for virus-
infected cells was performed as described previously, with minor modifications
(15, 27). Sf-9 cells (4  106 per 35-mm-diameter dish) were infected with BV at
an MOI of 10 in TNMFH medium with 10% fetal bovine serum. At specific time
points, the medium was removed and cells were washed twice with methionine-
free Grace’s medium and then labeled for 4 h in methionine-free Grace’s me-
dium containing 100 Ci of Translabel (ICN Biomedicals, Inc., Irvine, CA; a
mixture of about 80% [35S]methionine and 20% [35S]cysteine; specific activity,
1,200 Ci/mmol) per milliliter. Cells were harvested after labeling, and intracel-
lular protein extracts were prepared by treating the cells for 20 min on ice with
extraction buffer (50 mM Tris-HCl, pH 8.0–100 mM NaCI–1% Nonidet P-40–1%
Empigen BB (Albright & Wilson, Whitehaven, United Kingdom]) and then
microcentrifugation for 10 min. The soluble fractions were analyzed by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis on 10% gels. Then the
gel then was fixed, dried, and exposed to film.
For Western blot analysis, proteins were electrophoretically transferred to
nitrocellulose sheets using a semidry apparatus according to the recommenda-
tions of the manufacturer (American Bionetics, Hayward, CA). Blots were
probed with one of the following four primary antibodies: (i) LEF-4 rabbit
antiserum at a 1:1,000 dilution (30), (ii) LEF-3 mouse monoclonal antibody at a
1:1,000 dilution (21), (iii) GP64 mouse monoclonal AcV1 at a 1:250 dilution (61),
or (iv) PP31 rabbit antiserum at a 1:500 dilution (16). After incubation with a
1:2,500 dilution of peroxidase-conjugated secondary antibody, signals were de-
tected by enhanced chemiluminescence (ECL; Amersham Bioscience).
Cap marker synthesis and analysis. To prepare the tetraphosphate cap mark-
ers GppppG and m7GppppG, a D1/D12 mutant containing E192/194A substitu-
tions was made with the primer pair D1/D12-E192/194A-F (Table 1) and its
complement D1/D12-E192/194A-R on the template pET-14bD1/D12 (56). A
QuikChange site-directed mutagenesis kit (Stratagene) was used following the
protocol recommended by the manufacturer. Capping enzyme was expressed in
bacteria and purified on Talon (Clontech) affinity matrix. mRNA cap markers
were prepared as described previously (62). Template RNA was synthesized by
in vitro transcription of pBS-SK (Stratagene) previously digested with XbaI. The
linearized template was transcribed with T7 RNA polymerase using standard
conditions as recommended by the manufacturer (Promega). The resulting 93-
nucleotide RNAs were capped using the vaccinia virus capping enzyme D1/D12
or the RNA triphosphatase mutant D1/D12-E192/194A. Capping reactions con-
tained 50 mM Tris (pH 7.9), 5 mM dithiothreitol, 1.25 mM MgCl2, 10 M GTP,
2.5 M RNA ends, 0.6 M capping enzyme, and 10 Ci of [-32P]GTP with or
without 50 M AdoMet for mRNA cap methylation (56). The resulting cap
markers were subsequently purified by two rounds of precipitation with 2.5 M
LiCl to remove enzyme and free label and then digested with nuclease P1 (62).
Liberated caps were separated by thin-layer chromatography on polyethylene-
imine cellulose plates developed in 0.45 M ammonium sulfate. Plates were
exposed to a PhosphorImager screen for quantitation and analysis.
In vivo cap labeling and analysis. Sf-9 cells (5  107 cells in suspension
culture) were infected with virus at an MOI of 10. At 20 h postinfection, the cells
were washed twice with 50 ml of phosphate-free Grace’s medium and then
incubated in the presence of 5.0 mCi of [32P]orthophosphoric acid (285.5 Ci/mg)
diluted in 50 ml of phosphate-free Grace’s medium for 4 h at 28°C. After
incubation, the cells were harvested by centrifugation and mRNA was extracted
with an Oligotex mRNA midi kit (Qiagen) according to the manufacturer’s
instructions. In vivo mRNA cap analysis was adopted from a procedure described
previously by Latner et al. (31). Purified mRNA was digested with nuclease P1
overnight at 37°C, followed by treatment with calf alkaline phosphatase for 3 h
at 37°C. Cap markers were also treated with nuclease P1 and calf alkaline
phosphatase. Digested samples were then concentrated to approximately 1 l in
an 80°C hot plate and resuspended in 5 l of sequencing stop buffer (95%
formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF).
Samples were electrophoresed through a 20% polyacrylamide, 8 M urea, 1
Tris-borate-EDTA sequencing gel at 33 W with constant power for 4 h. The
excess free-labeled phosphate from this analysis was distributed between the
bottom of the gel and the lower buffer reservoir. After electrophoresis, the gel
was directly subjected to PhosphorImager analysis.
RESULTS
Analysis of viral replication in Sf-9 cells cotransfected with
vAcRTPase-PG and lef-4 mutant plasmids. To elucidate
the roles of LEF-4 and PTP/BVP RNA triphophatases in the
viral life cycle, a double-knockout mutant viral genome was
constructed in E. coli. First, the lef-4 gene was deleted by
homologous recombination. This knockout was designed so
that nearly the entire lef-4 ORF was replaced with the chlor-
amphenicol acetyltransferase (cat) marker. The resulting con-
struct contained only the first 131 bp downstream of the initi-
ating lef-4 AUG codon (Fig. 1A, top panel). It was necessary to
leave these residues, because the p39 promoter overlaps the 5
end of lef-4. The resulting bacmid, Lef-4KO, was confirmed by
PCR analysis and restriction enzyme digestions. The primer
pair C/D hybridizes to the 5 and 3 ends of the lef-4 gene and
generated PCR products of 1,803 bp for the parental (wt lef-4
construct) and 1,724 bp for LEF-4KO (data not shown). Be-
cause these fragments are close in size, restriction enzyme
digestion was used for further confirmation. Sequence analysis
predicted that MscI digestion of the wt fragment would pro-
duce two bands of 945 and 858 bp, while digestion of LEF-4KO
would produce bands of 1,043 and 681 bp (Fig. 1A, lanes 3 and
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4, respectively). This PCR-RFLP analysis confirmed that the
lef-4 gene had been replaced with the cat gene marker.
To construct the double-knockout bacmid, the ptp/bvp ORF
in the context of the Lef-4KO bacmid was replaced with a
Zeocin resistance marker. Construction of the double-knock-
out bacmid was confirmed by PCR-RFLP. The primer pair
A/B hybridizes to the 5 and 3 ends of the ptp/bvp gene. PCR
generated products of 913 bp for the wt and 893 bp for the
knockout construct (data not shown). MscI digestion of the wt
fragment produced two bands of 523 and 390 bp, as predicted
by the sequence, while the ptp/bvp knockout produced 636-
and 257-bp bands (Fig. 1A, lanes 1 and 2, respectively).
These results demonstrated that lef-4 and ptp/bvp were suc-
cessfully replaced by the chloramphenicol and Zeocin resis-
tance markers.
To facilitate the examination of virus infection, polyhedrin
and GFP were introduced into the polh locus of the double-
knockout bacmid by transposition using the Bac-to-Bac system
(Fig. 1B). The resulting construct was named vAcRTPase-
PG. The parental bacmid was also transposed with polyhedrin
and gfp for use as a positive control and was named vAc-PG.
vAcRTPase-PG bacmid DNA was prepared and trans-
fected into Sf-9 cells alone or cotransfected with plasmids
encoding wt PTP/BVP, wt LEF-4, or mutant versions of
LEF-4. Fluorescence microscopic analysis revealed similar pat-
terns of GFP in all the samples at 24 h postinfection (Fig. 2),
indicating that the transfection efficiencies were equivalent
for all DNAs. Three days postinfection, however, the vAc
RTPase-PG transfected cells exhibited no evidence of virus
spread. GFP expression was restricted to single cells in a man-
ner similar to that for the 24-h sample. In contrast, the Ac-PG
control showed widespread distribution of GFP and poly-
hedrin formation, as did cells cotransfected with vAc
RTPase-PG and a wt lef-4 sequence. The LEF-4K255A mutant
did not rescue the growth defect. These samples confirm our
previous results with BacP/LEF-4CmR, which demonstrated
that the guanylyltransferase activity of lef-4 is essential for viral
replication (30).
FIG. 1. Construction of double-knockout and rescue bacmids. (A) Strategy for deletion of lef-4 and ptp/bvp genes. Schematic diagram showing
location of genes and insertion of antibiotic resistance markers. Positions of primer pairs used to confirm disruption of lef-4 or ptp/bvp are shown
by arrows. The table at the lower left summarizes predicted results for PCR-RFLP using appropriate primer pairs for each locus. Actual results
are shown on the lower right. (B) Schematic diagrams of vAc-PG and rescue bacmids vAcRTPase-PGLEF-4, vAcRTPase-PGLEF-4/PTP, vAc
RTPase-PGLEF-4E2A, and vAcRTPase-PGLEF-4E2A/PTP, showing the genes inserted into the polyhedrin (polh) locus by Tn7-mediated
transposition. PCR analysis (on the bottom right) using the M13-reverse and specific gene primers, whose location is shown on the schematic
diagram, to confirm transposition of the rescue constructs. The table shows templates, primers and expected PCR-RFLP sizes. KO, knockout; Ac,
AcMNPV; M, 100-bp DNA size markers.
FIG. 2. Analysis of viral replication in Sf-9 cells cotransfected with vAcRTPase-PG and lef-4 or ptp/bvp constructs. Cells were transfected
with control bacmid DNA (panels A and I) or the double-knockout RTPase bacmid (RTPase-PG) alone (panels B and J) or cotransfected with
plasmids encoding wt lef-4 (panels C and K), ptp/bvp (panels D and L), lef-4 mutant E9/11A (panels E and M), lef-4 mutant R51A (panels F and
N), lef-4 mutant E181/183 (panels G and O), or lef-4 mutant K255A (panels H and P). Cells were analyzed by fluorescence microscopy at 24 h
(panels A to H) and 48 h (panels I to P) posttransfection.
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Cotransfection of a plasmid encoding ptp/bvp failed to res-
cue the double mutant. At 72 h postinfection, these cells
showed no evidence of polyhedron formation and GFP was
restricted to single cells, similar to the case for the K255A
mutant. This result was expected, because the ptp/bvp construct
could not restore guanylyltransferase activity.
We then tested whether RNA triphosphatase mutants of
lef-4 could rescue the double mutant. Three different mutant
versions were analyzed. Previously, we showed that all three of
these had low to undetectable RNA triphosphatase activities
(28). Two mutants contained alanine substitutions in pairs of
conserved glutamic acid residues (E9/11A and E181/183A).
Crystallographic analysis of the vaccinia virus ortholog has
demonstrated that these residues chelate the essential divalent
metal ion (36). Alanine substitution at R51 impairs activity,
because this residue contacts the gamma phosphate and posi-
tions it for cleavage (28, 36, 41).
Cells cotransfected with vAcRTPase-PG and one of the
three different LEF-4 RNA triphosphatase mutants (E9/11A,
R51A, or E181/183A) exhibited widespread patterns of GFP
distribution and polyhedron formation, similar to that of vAc
RTPase-PG cotransfected with wt lef-4. The finding that
lef-4 RNA triphosphatase mutants could rescue virus produc-
tion, even in the absence of ptp/bvp, suggests that neither RNA
triphosphatase function is required for viral replication.
Construction and analysis of repair bacmids. To further
characterize the extent of the RNA triphosphatase defects on
viral replication, repair viruses were constructed containing wt
lef-4, mutant lef-4, or ptp/bvp genes inserted at the polyhedrin
locus of the double-knockout bacmid by transposition (Fig.
1B). Four different repair bacmids were constructed. One con-
tained only the wt lef-4 gene, which should provide all func-
tions of lef-4, but does not restore ptp/bvp. This virus was
named vAcRTPase-PGLEF-4. The second was an RNA
triphosphatase mutant version of lef-4 containing substitutions
at E181/183A, called vAcRTPase-PGLEF-4E2A. This mutant
was chosen because it had the lowest RNA triphosphatase
activity among the three mutants tested (28). The third bac-
mid, which restored both wt lef-4 and the ptp/bvp gene, was
called vAcRTPase-PGLEF-4/PTP. Finally, a construct con-
taining the E181/183A mutant version of lef-4 and wt ptp/bvp,
called vAcRTPase-PGLEF-4E2A/PTP, was made. All con-
structs were confirmed by PCR analysis by using M13 reverse
and gene-specific primers. The relative positions of the primers
and expected sizes of the PCR products generated from the
bacmid constructs are illustrated in Fig. 2B. Results from these
analyses were consistent with the expectations, indicating suc-
cessful transposition of the intended genes.
All four repair bacmids and the control vAc-PG bacmid
were separately transfected into Sf-9 cells, and BV stocks were
produced and their titers were determined. Then a one-step
growth curve experiment was performed at an MOI of 5, and
infectious virus production was measured at different times
postinfection (Fig. 3). The growth curve patterns for all of the
repair bacmids were essentially the same as those of the con-
trol, even for vAcRTPase-PGLEF-4E2A, which lacks both
virus-encoded RNA triphosphatase activities. The result of this
more stringent test of viral replication was consistent with
those of the transfection experiments, again indicating that
neither RNA triphosphatase function was essential for virus
replication.
Analysis of late gene expression in mutant bacmids. Al-
though there was no apparent effect on production of budded
virus, we wanted to analyze the expression of viral late genes to
look for more subtle effects. In these experiments, we com-
pared only the control virus vAc-PG and the virus lacking both
RNA triphosphatases vAcRTPaseLEF-4E2A. We first exam-
ined LEF-4 expression to confirm that it was expressed at
normal levels as expected (Fig. 4A, top panel). Immunoblots
with polyclonal LEF-4 antiserum revealed that the lef-4 pro-
moter translocated to the polyhedrin locus drove the expres-
sion of LEF-4 at essentially the same levels as those of the
native promoter. The expression of LEF-3 was also unaffected
by the lef-4 RTPase mutation. This result was expected because
lef-3 is a delayed early gene and should not be dependent upon
the viral-encoded RNA polymerase (Fig. 4A, second panel).
Two genes that are regulated by tandem delayed early and late
promoters were analyzed next. These two genes, pp31 and
gp64, are expressed during both the early and late phases, but
the accumulation of protein is mainly due to the stronger late
promoters (4, 18). The expression patterns of both of these
proteins in the mutant-infected cells were essentially indistin-
guishable from that of the control.
Polyhedrin expression was analyzed by the staining of SDS
gels with Coomassie brilliant blue (Fig. 4B). Only the deter-
gent-insoluble fraction was analyzed after the disruption of
polyhedra with alkali. For polyhedrin analysis, we also examined
two additional repair viruses, because we noticed a decrease in
the accumulation of polyhedrin in the vAcRTPaseLEF-4E2A-
infected cells relative to vAc-PG. This decrease was particularly
evident in the 24-h sample. vAC-PG cells accumulated sufficient
polyhedrin for detection by Coomassie staining, while polyhedrin
was not evident at this time in the vAcRTPaseLEF-4E2A sample
FIG. 3. One-step growth curve of vAc-PG, vAcRTPase-PGLEF-4,
vAcRTPase-PGLEF-4/PTP, vAcRTPase-PGLEF-4E2A, and vAc
RTPase-PGLEF-4E2A/PTP. Sf-9 cells were infected with the indicated
viruses at an MOI of 5. Cell culture supernatants were harvested at the
indicated times postinfection and assayed for the production of infec-
tious virus by the TCID50 assay. Each data point represents the average
titer derived from independent duplicate sample. Bars represent stan-
dard errors.
5578 LI AND GUARINO J. VIROL.
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
(Fig. 4B, compare lanes 3 and 4). Cells infected with the lef-4 wt
repair virus vAcRTPaseLEF-4 showed polyhedrin accumula-
tion at 24 h, as did the cells infected with vAcRTPaseLEF-4/PTP,
although accumulation levels for both of these samples were
less than that for the control (Fig. 4B, lanes 3 to 6). By 36 and
48 h postinfection, polyhedrin accumulated to high levels in the
double-RTPase mutant, although it was still approximately
20% lower than control levels (Fig. 4B, compare lanes 11
and 12).
Total viral protein synthesis was also measured by protein
pulse labeling and gel analysis of the detergent-soluble fraction
of infected cells. Cells infected with mutant virus lacking both
RNA triphosphatases appeared to synthesize viral proteins
with kinetics similar to those of the control virus (Fig. 5).
Although the exact identity of the protein bands is unknown,
virus-specific protein bands appeared at the same times in both
samples. Some bands, however, persisted longer in the mutant
samples than in the control. This persistence was especially
evident in the two 48-h samples, where there was only one
band in the upper half of the gel in the control sample, while
numerous bands were evident in the double-RTPase mutant
sample.
Analysis of viral mRNA caps. The fact that viral protein
synthesis was unaffected by the absence of RNA triphos-
phatase activity suggested that viral mRNA caps were effi-
ciently formed in the absence of this enzyme. To directly test
this suggestion, we radiolabeled RNAs with inorganic 32P from
20 to 24 h postinfection, a time at which viral RNA synthesis is
maximal and host RNA synthesis has been suppressed. Viral
mRNA was purified on oligo(dT) columns, and caps were
liberated by treatment with P1 nuclease and calf intestinal
FIG. 4. Western blot analysis of viral protein expression. (A) Sf-9 cells were infected with the double-mutant virus vAcRTPase-PGLEF-4E2A
or the control vAc-PG at an MOI of 5. Cells were harvested at the indicated times, and detergent-soluble protein extracts were separated on SDS
gels. Each lane represents 1  104 cells. The lane labeled UI represents uninfected cells. Time zero is the end of a 1-h adsorption period. Extracts
were probed with antibody against rabbit antiserum raised against LEF-4 or PP31 or mouse monoclonal antibodies against LEF-3 or GP64.
(B) Analysis of polyhedrin expression in cells infected with vAC-PG (P), vAcRTPase-PGLEF-4E2A (4A), vAcRTPase-PGLEF-4 (4), or vAc
RTPase-PGLEF-4/PTP (4/P). Cells were harvested at the indicated times and detergent-insoluble extracts were separated on 12% acrylamide gels
and stained with Coomassie brilliant blue.
FIG. 5. Pulse-labeling time course of viral protein synthesis. Sf-9
cells were infected with the double-mutant virus vAcRTPase-
PGLEF-4m or the control vAc-PG at an MOI of 5. At different times
postinfection, cells were pulse labeled with [35S]methionine-cysteine
for 4 h. At the end of the labeling period, detergent-soluble protein
extracts were prepared and analyzed on an SDS-10% polyacrylamide
gel. The times above each lane represent the harvest time after a 4-h
labeling period. Each lane represents 1  104 cells. The positions of
molecular markers are shown on the left. UI, uninfected cells.
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phosphatase. We were unable to efficiently separate the caps
from the background of free phosphate on thin-layer chro-
matograms, because most of the radiolabel in the RNA sam-
ples was composed of internal nucleotides and was released as
free phosphate. Therefore, we analyzed the samples on 20%
acrylamide gels, which yielded cleaner separations. First, how-
ever, we wanted to confirm that the gels were capable of
separating tetraphosphate caps, which would be generated by
the complete absence of RNA triphosphatase activity, from
normal triphosphate caps. Triphosphate caps were synthesized
using the vaccinia virus capping enzyme D1/D12, a het-
erodimer that contains RNA triphosphatase, guanylyltrans-
ferase, and cap methyltransferase activities (63). Accurate syn-
thesis of the markers was verified by thin-layer chromatograms
(Fig. 6A). In the absence of Ado-Met, D1/D12 adds a GMP
cap to exogenous RNA, which was synthesized by T7 RNA
polymerase. Since the 5 residue on this RNA is G, the cap
structure is GpppG (Fig. 6A, lane 3). In the presence of Ado-
Met, the cap is methylated to produce m7GpppG (Fig. 6A, lane
1). Tetraphosphate caps were produced using a mutant version
of the vaccinia enzyme containing alanine substitutions at glu-
tamic acid residues 192 and 194 (63), which are equivalent to
the LEF-4 residues 181 and 183. In the absence of RNA
triphosphatase activity, the major product is a tetraphosphate
cap (Fig. 6A, lane 4). A minor amount of triphosphate cap was
made, which is likely due to residual triphosphatase activity.
The addition of Ado-Met efficiently converts the minor
amount of triphosphate cap to methylated cap, but very little
tetraphosphate cap is methylated, because it does not fit into
the methyltransferase active site (Fig. 6A, lane 2).
Acrylamide gel electrophoresis of the same cap markers
revealed that this method was also capable of cleanly separat-
ing the different species (Fig. 6, compare lanes 1 to 4 of both
panels). Cap migration was not affected by treatment of the
markers with calf intestinal phosphatase, which was necessary
to reduce background in the viral RNAs labeled in vivo (data
not shown). A comparison of the viral RNA caps revealed that
they migrated faster than did the m7GpppG marker. We were
unable to definitely identify the structure of this cap, but be-
lieve that it represents GpppNm. Significantly, however, RNAs
from the control virus Ac-PG and the double-RNA triphos-
phatase mutant migrated at exactly the same position (Fig. 6B,
lanes 5 and 6), indicating that cap formation was unaffected by
the RNA triphosphatase mutations in this virus.
Construction of a LEF-4 quadruple mutant. We next con-
sidered the possibility that the lack of a phenotype associated
with the LEF-4 RTPase E181/183A mutation was due to re-
sidual RNA triphosphatase activity. This possibility seemed
somewhat unlikely, because mutation of a single one of the
four glutamates that chelate metal is known to be lethal in
yeast (Saccharomyces cerevisiae) (22). Still, we decided to test
this idea by constructing a rescue mutant in which all four che-
lating glutamates (E9, E11, E181, and E183) were mutated to
alanines. This bacmid construct was named vAcRTPaseLEF-4E4A.
The transfection of the mutant bacmid DNA resulted in the
production of viable progeny after transfection into insect cells
(data not shown). A single-step growth curve showed that it
grew at least as well as the parental construct vAC-PG (Fig. 7).
The quadruple mutant virus was apparently normal in all re-
spects, except for a defect in the production of polyhedrin
(data not shown).
DISCUSSION
By exploiting a lef-4 and ptp/bvp double-mutant virus, we
have been able to probe the biological role of LEF-4 and
PTP/BVP in replication of AcMNPV in Sf-9 cells. Our results
indicate a surprising conclusion that RNA triphosphatase ac-
tivity is neither required for viral replication in tissue culture
nor necessary for the formation of a 5 cap structure on late
viral mRNAs. In the absence of both RNA triphosphatase
functions, the production of double-mutant progeny virus was
nearly identical to a virus possessing both of these functions. In
addition, protein pulse labeling and Western blotting experi-
ments showed that there was little difference between the dou-
ble-mutant and control viruses with respect to the expression
of late viral genes, although the expression of polyhedrin was
FIG. 6. Cap structures of viral RNAs. (A) Preparation of m7GppppG,
m7GpppG, GppppG, and GpppG markers. Capping reactions contained
50 mM Tris (pH 7.9), 5 mM dithiothreitol, 1.25 mM MgCl2, 10 M GTP,
2.5 M RNA ends, and 0.6 M wt (lanes 1 and 3) or mutant (lanes 2 and
4) vaccinia virus D1/D12 and 12.5 Ci of [-32P]GTP with () (lanes
1 and 2) or without () (lanes 3 and 4) 50 M AdoMet. Caps were
liberated by nuclease P1 digestion and separated by thin-layer chro-
matography on polyethyleneimine cellulose plates in 0.45 M ammo-
nium sulfate. The positions of the methylated caps are indicated on the
left and nonmethylated caps on the right. (B) Analysis of baculovirus
mRNA caps. Sf-9 cells (5  107) in a 50-ml spinner flask were infected
with vAc-PG (lane 5) or vAcRTPase-PGLEF-4m (lane 6) at an MOI
of 10 and labeled with 5.0 mCi of [32P]orthophosphoric acid (285.5
Ci/mg) from 20 to 24 h postinfection. mRNA was extracted from cells,
digested with nuclease P1 and treated with calf alkaline phosphatase.
Digested samples were electrophoresed on a 20% polyacrylamide, 8-M
urea sequencing gel. The cap markers are the same as those described
for panel A. The position of the unknown (U) viral cap is indicated on
the right. After electrophoresis, the gel was directly subjected to
PhosphorImager analysis.
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affected. Moreover, mRNA cap structure analysis indicated
that the double mutant had a 5 cap structure that was the
same as that of the control virus.
The 5 m7GpppN cap plays an essential role in the life cycle
of eukaryotic cellular and viral mRNA and is required for
efficient pre-mRNA splicing, export, stability, and translation.
Cellular enzymes find their RNA substrates through interac-
tions with RNA polymerase II (6, 43). RNA viruses, which
utilize their own RNA-dependent RNA polymerases, have
evolved diverse strategies to contend with the capping prob-
lem. Vesicular stomatitis virus (1, 32, 33), alphavirus (2), and
Sindbis virus (54) encode their own enzymes that specifically
cap and methylate their positive-strand transcripts, while in-
fluenza virus steals caps from cellular transcripts (34, 52).
Picornaviruses and hepatitis C virus adopt unique RNA struc-
tures that bypass the cap requirement for stability and allow
internal initiation of mRNA translation (26, 50). DNA viruses,
on the other hand, employ somewhat less adventurous strate-
gies. The mRNAs of retroviruses and most nuclear DNA vi-
ruses (e.g., papovaviruses, adenoviruses, and herpesviruses)
are transcribed by cellular RNA polymerase II and are capped
by the cellular capping and methylating enzymes. A few DNA
virus families, however, encode their own RNA polymerases
and mRNA capping enzymes; these include poxviruses, which
replicate entirely in the cytoplasm (44), and African swine
fever virus, which has a cytoplasmic replication phase (51).
Among all the DNA viruses, baculoviruses are unique in that
they employ host RNA polymerase II for early gene transcrip-
tion and encode their own RNA polymerases for late mRNA
synthesis.
The notion that baculoviruses encode their own enzymes for
mRNA capping gained currency in light of the in vitro RNA
triphosphatase and guanylyltransferase activities of LEF-4, a
subunit of viral RNA polymerase. The presence of ptp/bvp with
RNA triphosphatase activity challenged the potential role of
LEF-4 as the sole RNA triphosphatase involved in the capping
of viral late mRNAs. Crystallography (5) and domain swap
studies (42) between baculovirus and mammalian enzymes
suggested that this enzyme might provide a backup mechanism
for catalyzing the RNA triphosphatase step in the capping
pathway. After our initial results with a lef-4 single-knockout
virus with three different versions of LEF-4 triphosphatase
mutants indicated that its triphosphatase activity is not re-
quired for viral replication (unpublished observations), we as-
sumed that PTP/BVP was supplying the essential triphos-
phatase function. To our surprise, however, we found that the
deletion of the ptp/bvp gene, even in the context of a LEF-4
RNA triphosphatase mutation, had no effect on viral replica-
tion or on the RNA cap structure.
This intriguing result raises the question of which enzyme is
responsible for the hydrolysis of 	-phosphate from triphos-
phate-terminated nascent RNA strands. We considered the
possibility that residual activity from the E181/183A mutant
was sufficient for mRNA capping, although it had undetectable
levels of RNA triphosphatase when assayed in vitro (28). Fig-
ure 6 shows the effect of similar mutations on the vaccinia virus
RNA capping enzyme. In the absence of RTPase activity, tet-
raphosphate caps were formed, and these were inefficiently
methylated (63). In S. cerevisiae, alanine substitution of even a
single residue corresponding to the conserved LEF-4 residues
E9, E11, R51, E181, or E183 was lethal (22). In our experi-
ments, we tested mutant versions containing pairs of glutamic
acid residue substitutions that should have even lower residual
activities, but these still supported growth. To further impair
the RTPase activity of LEF-4, however, we constructed a mu-
tant version containing all four essential glutamates mutated to
alanine and found that viral replication was still supported.
Two possible explanations remain for our observations that
cap structure and viral replication were unaffected by the com-
plete absence of known RNA triphosphatases. One is that
baculoviruses encode another RNA triphosphatase gene that
has not been identified and the other is that the cellular en-
zyme provides this necessary function. While plausible, the first
explanation seems unlikely. Baculoviruses are the only known
genomes that encode both types of RNA triphosphatases
known to be involved in cap formation. Metal-dependent en-
zymes like LEF-4 are found in some DNA viruses and fungi,
while metal-independent cysteine phosphatases are used in
plants and metazoans. Conserved residues for both of these
families are now well defined, and we have not been able to
identify additional orthologs in AcMNPV.
A host enzyme could provide RNA triphosphatase activity.
Although host protein synthesis is shut down during the late
phase of infection, it is likely that the enzyme persists. How-
ever, the fact that cellular capping enzymes are directed to
their substrates through interactions with the C-terminal do-
main of RNA polymerase II has been well documented (6, 43).
Baculovirus RNA polymerases lack this feature, which we pre-
sume is why they have evolved their own capping enzymes. The
structure of baculovirus RNA polymerase is unknown, but it
seems reasonable to propose that the active sites of LEF-4 are
oriented so that RNA is capped as it leaves the polymerase
tunnel. In other systems, capping has been shown to occur
cotranscriptionally, and cellular enzymes cannot cap exoge-
nous RNAs (12, 20). Indeed, we have been unable to demon-
strate capping of exogenous RNAs with either purified poly-
merase or the single-subunit LEF-4 (J. Jin and L. Guarino,
FIG. 7. One-step growth curve of vAc-PG and vAcRTPase-
PGLEF-4E4A/PTP. Sf-9 cells were infected with the indicated viruses at an
MOI of 5. Cell culture supernatants were harvested at the indicated
times postinfection and assayed for the production of infectious virus
by the TCID50 assay. Each data point represents the average titer
derived from an independent duplicate sample.
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unpublished data). The vaccinia virus capping enzyme D1/D12
is an exception to this rule, and that is why it has become a
useful tool for capping RNAs after in vitro transcription. We
expect, however, that the insect cell capping enzymes would
not be attracted to the viral RNA polymerase and may not
have sufficient access to the nascent RNA to dephosporylate it
cotranscriptionally. We attempted to test whether cellular cap-
ping enzymes were involved in late RNA synthesis through
RNA silencing studies, but this analysis is complicated by the
fact that early viral RNAs require the host capping enzymes.
This experiment would require the ability to rapidly inactivate
the host enzyme as the virus enters the late phase, for example,
with a temperature-sensitive mutant. We doubt that RNA si-
lencing, which lacks the ability to fine-tune the timing of the
effect, would give a clean answer.
Unlike the case for S. cerevisiae, the Candida albicans RNA
triphosphatase gene is nonessential (9). Cells with null alleles
were viable, although they grew more slowly. Cap structures
were also affected. While the altered structures were not fully
characterized, their migration appeared to be consistent with
an unmethylated tetraphosphate cap. While this result suggests
that RNA triphosphatases are not always essential, it differs
from the baculovirus case in that growth of the viruses was not
affected, nor was the cap structure altered.
We were unable to identify the cap structure on viral RNAs.
It migrated faster than the m7GpppG marker, and only slightly
slower than the unmethylated marker GpppG. Its migration
suggests that it may correspond to GpppNm. Ribose methyl-
ation has a lesser effect on the mobility of cap structures than
does N7 methylation, because the former alters mass but not
charge. The methylation on both sites (m7GpppGm) results in
a mobility that is slower than that of the m7GpppG marker
(31). If correct, this cap structure would be consistent with the
presence of mtase-1 [an RNA cap (2-O)-methyltransferase] in
the genome of AcMNPV, but there are no good candidates for
an RNA cap (guanine-7)-methyltransferase enzyme. These
two cap methylations are catalyzed by enzymes with different
active site structures (10, 24), and it is unlikely that mtase-1
could catalyze both reactions.
Still unresolved by our work is the question of why group I
baculoviruses encode the RNA triphosphatase gene ptp/bvp.
The gene is not essential for viral replication in cell culture, but
the work of Kamita et al. (29) suggests that it plays an impor-
tant role in the virus lifestyle. Viruses with deletions in this
gene were unable to induce wandering, a behavior that results
in infected insects crawling to the tops of vegetation and aids in
virus dispersion. The mechanism for its action is unknown, but
the role of the protein for ptp/bvp in RNA processing suggests
that it may be mediated through RNA regulatory mechanisms.
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